Does steroid sulfatase deficiency influence postpartum psychosis risk?

Trends in Molecular Medicine

Volumn 18, Issue 5, 2012, Pages 256-262

  Davies, William ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

5 HT 2c receptor; Anterior pituitary gland; Dehydroepiandrosterone sulfate; Oestrogen; Serotonin; Steroid sulfatase; Thyroid gland

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CORTICOTROPIN; PRASTERONE; SEROTONIN 5 RECEPTOR; STEROID HORMONE; STERYL SULFATASE;

ADENOHYPOPHYSIS; BASAL GANGLION; BRAIN FUNCTION; CHILDBIRTH; COGNITION; CONFUSION; DELUSION; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE LOCUS; GENETIC LINKAGE; GENETIC PREDISPOSITION; HUMAN; HYPERACTIVITY; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PUERPERAL PSYCHOSIS; REVIEW; RISK; STEROID METABOLISM; THINKING; UPREGULATION;

FEMALE; HUMANS; POSTPARTUM PERIOD; PSYCHOTIC DISORDERS; RISK FACTORS; STERYL-SULFATASE;

ANIMALIA;

EID: 84860524837     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2012.03.001     Document Type: Review

References (52)

1. Sit D., et al. A review of postpartum psychosis. J. Womens Health (Larchmt) 2006, 15:352-368.
2. Wisner K.L., et al. Symptomatology of affective and psychotic illnesses related to childbearing. J. Affect. Disord. 1994, 30:77-87.
3. Valdimarsdottir U., et al. Psychotic illness in first-time mothers with no previous psychiatric hospitalizations: a population-based study. PLoS Med. 2009, 6:e13.
4. Jones I., Craddock N. Familiality of the puerperal trigger in bipolar disorder: results of a family study. Am. J. Psychiatry 2001, 158:913-917.
5. Jones I., et al. Bipolar affective puerperal psychosis: genome-wide significant evidence for linkage to chromosome 16. Am. J. Psychiatry 2007, 164:1099-1104.
6. Riley D.M., Watt D.C. Hypercalcemia in the etiology of puerperal psychosis. Biol. Psychiatry 1985, 20:479-488.
7. Mortaud S., et al. Murine steroid sulfatase gene expression in the brain during postnatal development and adulthood. Neurosci. Lett. 1996, 215:145-148.
8. Selcer K.W., et al. Immunohistochemical analysis of steroid sulfatase in human tissues. J. Steroid Biochem. Mol. Biol. 2007, 105:115-123.
9. Pasqualini J.R. Enzymes involved in the formation and transformation of steroid hormones in the fetal and placental compartments. J. Steroid Biochem. Mol. Biol. 2005, 97:401-415.
10. Reed M.J., et al. Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr. Rev. 2005, 26:171-202.
11. Craig M.C., Murphy D.G. Estrogen: effects on normal brain function and neuropsychiatric disorders. Climacteric 2007, 10:97-104.
12. Joffe H., Cohen L.S. Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge?. Biol. Psychiatry 1998, 44:798-811.
13. Riecher-Rossler A., Kulkarni J. Estrogens and gonadal function in schizophrenia and related psychoses. Curr. Top. Behav. Neurosci. 2011, 8:155-171.
14. Wieck A. Oestradiol and psychosis: clinical findings and biological mechanisms. Curr. Top. Behav. Neurosci. 2011, 8:173-187.
15. Gentile S. The role of estrogen therapy in postpartum psychiatric disorders: an update. CNS Spectr. 2005, 10:944-952.
16. Kent L., et al. X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits. J. Med. Genet. 2008, 45:519-524.
17. Milunsky J., et al. Schizophrenia susceptibility gene locus at Xp22.3. Clin. Genet. 1999, 55:455-460.
18. Stergiakouli E., et al. Steroid sulfatase is a potential modifier of cognition in attention deficit hyperactivity disorder. Genes Brain Behav. 2011, 10:334-344.
19. Perumal A.S., Robins E. Regional and subcellular distribution of aryl- and steroid sulfatases in brain. Brain Res. 1973, 59:349-358.
20. Perez-Costas E., et al. Basal ganglia pathology in schizophrenia: dopamine connections and anomalies. J. Neurochem. 2010, 113:287-302.
21. Vukadinovic Z., Rosenzweig I. Abnormalities in thalamic neurophysiology in schizophrenia: could psychosis be a result of potassium channel dysfunction?. Neurosci. Biobehav. Rev. 2012, 36:960-968.
22. Geyer M.A., Vollenweider F.X. Serotonin research: contributions to understanding psychoses. Trends Pharmacol. Sci. 2008, 29:445-453.
23. Ibrahim, H.M. and Tamminga, C.A. (2012) Treatment of cognitive dysfunction in schizophrenia. Curr. Pharm. Biotechnol. (in press).
24. Trent S., et al. Altered serotonergic function may partially account for behavioral endophenotypes in steroid sulfatase-deficient mice. Neuropsychopharmacology 2011, 37:1267-1274.
25. Chen C., et al. A genome wide detection of quantitative trait loci on pig maternal infanticide behavior in a large scale White Duroc × Erhualian resource population. Behav. Genet. 2009, 39:213-219.
26. Quilter C.R., et al. Porcine maternal infanticide as a model for puerperal psychosis. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2007, 144B:862-868.
27. Quilter C.R., et al. Gene expression profiling in porcine maternal infanticide: a model for puerperal psychosis. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2008, 147B:1126-1137.
28. Coyle N., et al. Variation at the serotonin transporter gene influences susceptibility to bipolar affective puerperal psychosis. Lancet 2000, 356:1490-1491.
29. Kumar H.B., et al. Serotonergic candidate genes and puerperal psychosis: an association study. Psychiatr. Genet. 2007, 17:253-260.
30. Doucet S., et al. Interventions for the prevention and treatment of postpartum psychosis: a systematic review. Arch. Womens Ment. Health 2011, 14:89-98.
31. Herrick-Davis K., et al. Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine 2C receptors. J. Pharmacol. Exp. Ther. 2000, 295:226-232.
32. Meltzer H.Y., Massey B.W. The role of serotonin receptors in the action of atypical antipsychotic drugs. Curr. Opin. Pharmacol. 2011, 11:59-67.
33. Rauser L., et al. Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine (2C) receptor. J. Pharmacol. Exp. Ther. 2001, 299:83-89.
34. Rhodes M.E., et al. Enhanced plasma DHEAS, brain acetylcholine and memory mediated by steroid sulfatase inhibition. Brain Res. 1997, 773:28-32.
35. Reddy D.S. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog. Brain Res. 2010, 186:113-137.
36. Karam C.S., et al. Signaling pathways in schizophrenia: emerging targets and therapeutic strategies. Trends Pharmacol. Sci. 2010, 31:381-390.
37. Trent S., et al. Steroid sulfatase-deficient mice exhibit endophenotypes relevant to attention deficit hyperactivity disorder. Psychoneuroendocrinology 2012, 37:221-229.
38. Nicolas L.B., et al. Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice. Brain Res. 2001, 922:216-222.
39. Davies W., et al. Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention. Biol. Psychiatry 2009, 66:360-367.
40. Brookes K.J., et al. Association of the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2008, 147B:1531-1535.
41. Freeman M.E., et al. Prolactin: structure, function, and regulation of secretion. Physiol. Rev. 2000, 80:1523-1631.
42. Raffin-Sanson M.L., et al. Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur. J. Endocrinol. 2003, 149:79-90.
43. Pariante C.M. Pituitary volume in psychosis: the first review of the evidence. J. Psychopharmacol. 2008, 22:76-81.
44. Bergink V., et al. Prevalence of autoimmune thyroid dysfunction in postpartum psychosis. Br. J. Psychiatry 2011, 198:264-268.
45. Wisner K.L., Stowe Z.N. Psychobiology of postpartum mood disorders. Semin. Reprod. Endocrinol. 1997, 15:77-89.
46. Elashoff M., et al. Meta-analysis of 12 genomic studies in bipolar disorder. J. Mol. Neurosci. 2007, 31:221-243.
47. Gershon E., et al. After GWAS: searching for genetic risk for schizophrenia and bipolar disorder. Am. J. Psychiatry 2011, 168:253-256.
48. Hickey P.F., Bahlo M. X chromosome association testing in genome-wide association studies. Genet. Epidemiol. 2011, 35:664-670.
49. Fernandes N.F., et al. X-linked ichthyosis: an oculocutaneous genodermatosis. J. Am. Acad. Dermatol. 2010, 62:480-485.
50. Wolf O.T., Kirschbaum C. Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans. Brain Res. Brain Res. Rev. 1999, 30:264-288.
51. Bisi R.H. Dermatosis in a case of postpartum psychosis. Psychoanal. Q. 1956, 25:348-356.
52. Jones N.C., et al. Acute administration of typical and atypical antipsychotics reduces EEG gamma power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in gamma power. Int. J. Neuropsychopharmacol. 2011, 9:1-12.